Search results with tag "Trial summary"
EMPA-REG- CV Outcomes Trial Summary - RxFiles
www.rxfiles.caRXFILES TRIAL SUMMARY .R . APR 2016 – WWW XFILES CA Page 1 of 3 EMPA-REG: CV Outcomes Trial Summary Empagliflozin: Cardiovascular (CV) Outcomes and Mortality in Patients with Type 2 Diabetes Mellitus (T2DM) In patients with T2DM and at high risk of CV events, does empagliflozin reduce CV risk compared to placebo when added to standard care?
RXFILES TRIAL SUMMARY WWW JULY 2016; UPDATED MAY …
www.rxfiles.caRXFILES TRIAL SUMMARY WWW JULY 2016; UPDATED MAY 2017 – .RXFILES.CA Page 1 of 3 LEADER: Liraglutide VICTOZA CV Outcomes Trial Summary 1 Liraglutide: Cardiovascular (CV) Outcomes and Mortality in Patients with Type 2 Diabetes (T2DM) In patients with T2DM and at high risk of CV events, does liraglutide reduce CV risk compared to placebo when added to standard care?
RXFILES TRIAL SUMMARY O P B LK N 2012 F ARISTOTLE: vs ...
www.rxfiles.caRXFILES TRIAL SUMMARY ORIGINALLY PREPARED BY:M JIN, REVISED LKOSAR –UPDATED NOV 2012 WWW.RXFILES.CA Page 1 of 3 ARISTOTLE: Apixaban vs Warfarin in patients with Atrial Fibrillation 1 Apixaban for Reduction In STroke and Other ThromboemboLic Events in Atrial Fibrillation